Literature DB >> 11929034

Ascites and encephalopathy in chronic liver disease.

Winita Hardikar1.   

Abstract

Ascites and particularly encephalopathy in the setting of chronic liver disease are traditionally thought to be poor prognostic markers of end stage liver disease. Diagnostic and therapeutic approaches to these complications are based on experience with adult patients, however, differences in the spectrum of aetiologies causing end stage liver disease together with the relative resistance of the pediatric patient to encephalopathy impact on the management of such patients. The following is a review of current thinking in the aetiology and management of ascites and encephalopathy in the setting of chronic liver disease in children.

Entities:  

Mesh:

Year:  2002        PMID: 11929034     DOI: 10.1007/BF02859379

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  21 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

Review 2.  Glutamine as a pathogenic factor in hepatic encephalopathy.

Authors:  J Albrecht; M Dolińska
Journal:  J Neurosci Res       Date:  2001-07-01       Impact factor: 4.164

3.  Intensive enteral feeding in advanced cirrhosis: reversal of malnutrition without precipitation of hepatic encephalopathy.

Authors:  C P Charlton; E Buchanan; C E Holden; M A Preece; A Green; I W Booth; M J Tarlow
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

Review 4.  Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.

Authors:  F L Weber
Journal:  Dig Dis       Date:  1996       Impact factor: 2.404

5.  The prognostic significance of subclinical hepatic encephalopathy.

Authors:  I J Hartmann; M Groeneweg; J C Quero; S J Beijeman; R A de Man; W C Hop; S W Schalm
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 6.  Naturally occurring benzodiazepines: current status of research and clinical implications.

Authors:  P Sand; D Kavvadias; D Feineis; P Riederer; P Schreier; M Kleinschnitz; F C Czygan; A Abou-Mandour; G Bringmann; H Beckmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

Review 7.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

8.  Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation.

Authors:  K I Wayman; K L Cox; C O Esquivel
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

Review 9.  Cerebral changes in hepatic encephalopathy.

Authors:  A Watanabe
Journal:  J Gastroenterol Hepatol       Date:  1998-07       Impact factor: 4.029

10.  Choosing a pediatric recipient for orthotopic liver transplantation.

Authors:  J J Malatack; D J Schaid; A H Urbach; J C Gartner; B J Zitelli; H Rockette; J Fischer; T E Starzl; S Iwatsuki; B W Shaw
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.